The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8(+) T cell suppression of syncytia-inducing strains of HIV-1

被引:34
作者
Lacey, SF
McDanal, CB
Horuk, R
Greenberg, ML
机构
[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[2] BERLEX BIOSCI,DEPT IMMUNOL,RICHMOND,CA 94804
关键词
CD8; cells; virus suppression;
D O I
10.1073/pnas.94.18.9842
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Primary CD8(+) T cells from HIV+ asymptomatics can suppress virus production from CD4(+) T cells acutely infected with either non-syncytia-inducing (NSI) or syncytia-inducing (SI) HIV-1 isolates. NSI strains of HIV-1 predominantly use the CCR5 chemokine receptor as a fusion cofactor, whereas fusion of T cell line-adapted SI isolates is mediated by another chemokine receptor, CXCR4. The CCR5 ligands RANTES (regulated on activation, normal T cell expressed and secreted), macrophage inflammatory protein 1 alpha (MIP-1 alpha), and MIP-1 beta are HIV-1 suppressive factors secreted by CD8(+) cells that inhibit NSI viruses. Recently, the CXC chemokine stromal cell-derived factor 1 (SDF-1) nas identified as a ligand for CXCR4 and shown to inhibit SI strains. We speculated that SDF-1 might be an effector molecule for CD8(+) suppression of SI isolates and assessed several SDF-1 preparations for inhibition of MV-1(LAI)-mediated cell-cell fusion, and examined levels of SDF-1 transcripts in CD8(+) T cells. SDF-1 fusion inhibitory activity correlated with the N terminus, and the alpha and beta forms of SDF-1 exhibited equivalent fusion blocking activity. SDF-1 preparations having the N terminus described by Bleul et al. (Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. & Springer, T.A. (1996) J. Exp. Med. 184, 1101-1109) readily blocked HIV-1(LAI)-mediated fusion, whereas forms containing two or three additional N-terminal amino acids lacked this activity despite their ability to bind and/or signal through CXCR4. Though SDF-1 is constitutively expressed in most tissues, CD8 T cells contained extremely low levels of SDF-1 mRNA transcripts (<1 transcript/5,000 cells), and these levels did not correlate with virus suppressive activity. We conclude that suppression of SI strains of HIV-1 by CD8(+) T cells is unlikely to involve SDF-1.
引用
收藏
页码:9842 / 9847
页数:6
相关论文
共 41 条
[1]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[2]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
[3]   HIV SUPPRESSION BY INTERLEUKIN-16 [J].
BAIER, M ;
WERNER, A ;
BANNERT, N ;
METZNER, K ;
KURTH, R .
NATURE, 1995, 378 (6557) :563-563
[4]   The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry [J].
Bleul, CC ;
Farzan, M ;
Choe, H ;
Parolin, C ;
ClarkLewis, I ;
Sodroski, J ;
Springer, TA .
NATURE, 1996, 382 (6594) :829-833
[5]   A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].
Bleul, CC ;
Fuhlbrigge, RC ;
Casasnovas, JM ;
Aiuti, A ;
Springer, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109
[6]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[7]   A MOLECULAR CLASP IN THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 TM PROTEIN DETERMINES THE ANTI-HIV ACTIVITY OF GP41 DERIVATIVES - IMPLICATION FOR VIRAL FUSION [J].
CHEN, CH ;
MATTHEWS, TJ ;
MCDANAL, CB ;
BOLOGNESI, DP ;
GREENBERG, ML .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3771-3777
[8]   CD8(+) T-LYMPHOCYTE-MEDIATED INHIBITION OF HIV-1 LONG TERMINAL REPEAT TRANSCRIPTION - A NOVEL ANTIVIRAL MECHANISM [J].
CHEN, CH ;
WEINHOLD, KJ ;
BARTLETT, JA ;
BOLOGNESI, DP ;
GREENBERG, ML .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (11) :1079-1086
[9]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[10]  
CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128